SCHEMBL25910033

SCHEMBL25910033

CC(C)Nc1ncc(-c2ccc3cc(Oc4ccnc(N)c4Cl)ccc3n2)c(=O)n1C

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CSF1R P07333 6/20 0.51
▸ PDGFRA P16234 4/20 0.51
▸ PDGFRB P09619 3/20 0.51
▸ LCK P06239 2/20 0.51
▸ KIT P10721 1/20 0.51
▸ CYP2C9 P11712 1/20 0.51
▸ FLT3 P36888 1/20 0.51
▸ PTK6 Q13882 1/20 0.51
▸ KDR P35968 7/20 0.36
▸ SYK P43405 1/20 0.34
▸ MET P08581 11/20 0.34
▸ MST1R Q04912 2/20 0.33
▸ AURKA O14965 1/20 0.33
▸ RPS6KA5 O75582 1/20 0.33
▸ PIM1 P11309 1/20 0.33
▸ HGF P14210 1/20 0.33
▸ RPS6KB1 P23443 1/20 0.33
▸ MAPK9 P45984 1/20 0.33
▸ TEK Q02763 1/20 0.33
▸ BTK Q06187 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25912165 0.91 CSF1R (0.53) CSF1RPDGFRAPDGFRBLCKKIT
SCHEMBL25910813 0.91 CSF1R (0.41) CSF1RPDGFRAPDGFRBLCKKIT
SCHEMBL25910161 0.90 CSF1R (0.51) CSF1RPDGFRAPDGFRBLCKKIT
SCHEMBL25910692 0.89 CSF1R (0.40) CSF1RPDGFRAPDGFRBLCKKIT
SCHEMBL25910708 0.88 CSF1R (0.49) CSF1RPDGFRAPDGFRBLCKKIT
SCHEMBL25910028 0.85 CSF1R (0.53) CSF1RPDGFRAPDGFRBLCKKIT
SCHEMBL25911894 0.85 CSF1R (0.51) CSF1RPDGFRAPDGFRBLCKKIT
SCHEMBL25910918 0.84 CSF1R (0.35) CSF1RPDGFRAPDGFRBLCKKIT
SCHEMBL25914823 0.84 CSF1R (0.53) CSF1RPDGFRAPDGFRBLCKKIT
SCHEMBL25910037 0.84 CSF1R (0.50) CSF1RPDGFRAPDGFRBLCKKIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023125812-A1 SUBSTITUTED PYRIMIDONE DERIVATIVE, AND PHARMACEUTICAL COMPOSITION AND MEDICAL USE THEREOF 上海海雁医药科技有限公司 2023-07-06 — — WO disclosed
Send feedback